tiprankstipranks
Brainstorm Cell Therapeutics (BCLI)
OTHER OTC:BCLI
US Market
BCLI
Brainstorm Cell Therapeutics
RESEARCH TOOLSreports
Want to see BCLI full AI Analyst Report?

Brainstorm Cell Therapeutics (BCLI) Income Statement

572 Followers

Brainstorm Cell Therapeutics Income Statement

Last quarter (Q1 2026), Brainstorm Cell Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Brainstorm Cell Therapeutics's net income was $-2.13M. See Brainstorm Cell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -240.00K$ -265.00K$ -285.00K$ -260.00K
Operating Expenses
$ 9.95M$ 11.69M$ 21.17M$ 24.82M$ 24.54M
Depreciation and Amortization
$ 199.00K$ 240.00K$ 265.00K$ 285.00K$ 260.00K
EBITDA
$ -9.75M$ -11.31M$ -16.93M$ -23.99M$ -24.28M
Operating Income
$ -9.95M$ -11.69M$ -21.44M$ -24.82M$ -24.54M
Other Income/Expenses
$ -354.00K$ 70.00K$ 4.25M$ 545.00K$ 82.00K
Pretax Income
$ -10.31M$ 11.62M$ -17.19M$ -24.28M$ -24.46M
Net Income
$ -10.31M$ 11.62M$ -17.19M$ -24.28M$ -24.46M
Per Share Metrics
Basic EPS
$ -1.11$ 2.19$ -4.48$ -9.93$ -10.09
Diluted EPS
$ -1.11$ 2.19$ -4.48$ -9.93$ -10.09
Weighted Average Shares Outstanding
 9.27M 5.31M 3.84M 2.45M 2.42M
Weighted Average Shares Outstanding (Diluted)
 9.27M 5.31M 3.84M 2.45M 2.42M
Currency in USD

Brainstorm Cell Therapeutics Earnings and Revenue History